Acutus Medical is an arrhythmia management company. Co. designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Co.'s product portfolio includes access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters (available only in its European markets), mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Co.'s primary product is its AcQMap imaging and mapping system, which provides a paradigm-shifting approach to mapping the drivers and maintainers of arrhythmias with unmatched speed and precision. We show 15 historical shares outstanding datapoints in our coverage of AFIB's shares outstanding history.
Understanding the changing numbers of AFIB shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like AFIB versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching AFIB by allowing them to research AFIB shares outstanding history
as well as any other stock in our coverage universe. |
Free AFIB Email Alerts:
Video: Shares Outstanding Importance
